New James CEO Drives Cancer Innovation and Access at OSU Hospital

A Visionary Leader in Cancer Care

Dr. W. Kimryn Rathmell has always believed that the fight against cancer is a collective effort. No individual, no matter how accomplished, can succeed alone. This philosophy has guided her throughout her career, and it continues to shape her leadership at Ohio State University's Comprehensive Cancer Center - James (OSUCCC-James). In May, she officially became the new chief executive officer after a nationwide search, succeeding Dr. David Cohn, who had served as interim CEO for many years.

In an interview with The Dispatch on July 16, Rathmell emphasized the importance of collaboration between science and medicine. She described the synergy between these two fields as essential for advancing treatments and improving patient outcomes. "When science and practical medicine intersect, research thrives and patient care gets better," she said. Her background as both a scientist and a physician has allowed her to bridge this gap, using basic sciences to directly benefit cancer patients.

Rathmell’s journey into medicine began with a strong foundation in biology and chemistry. Although there was no formal biochemistry degree at the time, she felt that combining these disciplines provided a deeper understanding of biological processes. This interdisciplinary approach has remained central to her work. As a physician-scientist, she has dedicated her life to tackling complex medical challenges and ensuring that patients receive comprehensive care.

A Legacy of Innovation and Leadership

Before joining OSUCCC-James, Rathmell had already made a significant impact in the field of cancer research. She served as the director of the National Cancer Institute (NCI) and was instrumental in advancing the fundamental science behind kidney cancer research. Her academic journey took her through prestigious institutions such as Stanford University, where she earned a biophysics degree and completed her medical training. She also gained valuable experience through internships and residencies at the University of Chicago and the University of Pennsylvania.

Throughout her career, Rathmell has held professorships and leadership roles at the University of North Carolina Chapel Hill and Vanderbilt University. At these institutions, she led numerous clinical and translational trial programs while mentoring hundreds of junior researchers. These mentees, now tackling some of the most challenging problems in medicine, are a source of pride for her.

Her contributions to cancer research have been widely recognized. She has published over 300 peer-reviewed journal articles and has been a key resource for the National Institutes of Health for more than a decade. In 2022, she earned a master’s degree in health care management from Vanderbilt University, further expanding her expertise in the business side of healthcare. That same year, she received the American Cancer Society Medal of Honor, the organization’s highest award.

Expanding Access to Cancer Care

At OSUCCC-James, Rathmell is focused on building on the institution’s existing strengths while addressing critical gaps in access to care. She emphasizes the importance of engaging with communities across Ohio, not just in Columbus but throughout the state’s 88 counties. Her goal is to bring the center’s discoveries and specialists to every part of the state, rather than requiring patients to travel to Columbus for treatment.

One example of this approach is the mobile lung-cancer screening program, which uses telehealth follow-ups to reach patients in rural areas or those without reliable transportation. Rathmell, who grew up in rural Iowa, understands the unique challenges of accessing healthcare in these regions. She is excited about the potential of innovative solutions like clinical trials by mail and partnerships with local doctors and laboratories to eliminate barriers such as long drives or lack of transportation.

"FedEx gets everywhere, so why can't oncology get everywhere?" she asked, highlighting the need for creative approaches to ensure equitable care.

Navigating Challenges in Healthcare

Rathmell’s appointment came at a time of significant uncertainty in the healthcare landscape, particularly under the Trump administration, which brought changes to Medicaid and federal health funding. She remains vigilant about these developments, acknowledging the potential risks to patient access and care.

"We really don't want to get to where late-stage cancer diagnoses become the norm again," she said, reflecting on her early experiences in medicine. She believes that prevention and early detection must remain priorities in the face of these challenges.

Despite these concerns, Rathmell feels confident about the financial stability of OSUCCC-James. The institution has a well-balanced portfolio supported by grants, philanthropy, and clinical margins. She sees this as a strong foundation for continued innovation and growth.

"Thinking about opportunities to partner with industry and commercialize our discoveries is smart business," she said. "The mission is critical, and it absolutely has to continue."

As she steps into her new role, Rathmell remains committed to her vision: a future where cancer care is accessible, innovative, and driven by collaboration. Her leadership promises to bring fresh energy and a renewed focus to one of the nation’s leading cancer centers.